To get in touch with us or to schedule a live demo, please complete the form below. * Required Fields
Decision Lens, a leading provider of Web-based collaborative decision making software, has been selected by the pharmaceutical firm MedImmune for drug portfolio and related prioritized decision-making.
With this engagement, Decision Lens’s client list includes seven of the top twelve largest pharmaceutical companies in the world. Some of those companies include Genentech, Johnson & Johnson, and Pfizer. Decision Lens has also worked with the National Institutes of Health’s National Cancer Institute on program prioritization.
MedImmune is a Washington DC-area biotechnology firm, headquartered in Gaithersburg, MD. Best known for their child respiratory and flu vaccines, the company was acquired in 2007 by pharmaceutical giant AstraZeneca PLC. MedImmune is now the global biologics unit for AstraZeneca, with approximately 3,500 employees worldwide.
Decision Lens will provide software and services for MedImmune’s drug portfolio prioritization programs and other related decision-making.
“Decision Lens is doing great work in the pharmaceutical industry,” said Decision Lens CEO John Saaty. “This is a high stakes field, where the right decisions can influence not only corporate finances but the health of people worldwide. That’s a tremendous responsibility, and one we are proud to take on for the largest firms in the field.”
Decision Lens software is used widely throughout state and federal government agencies and across the Intelligence Community, with clients including the US Navy, the Joint Staff and CENTCOM. Decision Lens also serves numerous well-known national and international commercial clients such as Petrobras, Johnson and Johnson, Kraft, and Superbowl-winning Green Bay Packers, among other organizations.
Decision Lens develops progressive decision-making software solutions that allow organizations to make complex decisions more effectively and efficiently. Our collaborative software platform structures decisions, quantifies intangible factors, and evaluates choices that enable organizations to reach their goals.
Decision Lens improves the speed and quality of decision making, maximizes returns, and provides accountability and transparency for how decisions are made.
For more information, contact Decision Lens at 703-399-2100, visit http://www.decisionlens.com or follow us on Twitter @DecisionLens.